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Introduction: The lacrimal gland (LG) of the CD25-/- model of Sjögren’s syndrome (SS) has high interleukin (IL)-17,
IL-13 and interferon-gamma (IFN-γ) cytokines. The specific contribution of these cytokines to the onset and severity
of dacryoadenitis in the CD25-/- mice has not been evaluated.
Methods: CD25−/−IL-17A−/−, CD25−/−IL-17−/−IFN-γ−/− and CD25−/−IFN-γ−/− were used at 4, 8, 12, 16 weeks (W). Total
lymphocytic infiltration was evaluated by histology and characterized by flow cytometry. Epidermal growth factor (EGF)
concentration was measured in tears. Immunofluorescent staining evaluated expression of IFN-γ receptor (IFN-γR) and
apoptosis. Real-time PCR evaluated inflammatory and T cell-related cytokines expression in LG. Caspase-3, -8, -9 activities
was assayed in LG lysates. T helper cytokines were measured in serum by Luminex assay.
Results: The greatest total LG infiltration at 8 W was seen in CD25−/−IL-17A−/− (95%), followed by CD25−/− (71%) and
IL-17−/− (12%). Tear EGF concentration was in normal range in CD25−/− at 4 W and in very low levels in both CD25−/−
and CD25−/−IL-17A−/−. CD25−/− had high levels of inflammatory cytokines transcripts in LG compared to IL-17−/− mice;
however, CD25−/−IL-17A−/− had even higher IL-1β, IFN-γR, caspase-3, -8, -9 mRNA levels, greater immunoreactivity to
IFN-γR in LG acini, greater number of apoptotic+ cells and greater caspases activities in the LG at 8 W. CD25−/−IL-17A−/−
had lower IL-13 concentration and lower IL-13/IFN-γ ratio compared to CD25−/− in serum. CD25−/−IFN-γ−/− had lower
number of apoptotic+ cells and decreased caspase-3 expression in LG. CD25−/−IL-17−/−IFN-γ−/− had lower total
lymphocytic cell infiltration at 8 W (48%), CD4+T cell infiltration and expression of IFN-γR and apoptotic+ cells in the LG
and increased tear EGF concentration in tears.
Conclusions: IFN-γ is critical for LG destruction and secretory dysfunction in the CD25−/− model of SS. Altered balance
between IFN-γ and IL-13 in the CD25−/−IL-17A−/− mice accelerates LG destruction by increasing glandular apoptosis
and facilitating apoptosis through increased expression of IFN-γR by glandular epithelium and activation of caspases.
Targeting both IFN-γ and IL-17 may be beneficial for treating the LG inflammation in SS.* Correspondence: cintiadp@bcm.edu
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Sjögren’s syndrome (SS) is an autoimmune disorder
characterized by progressive lymphocytic infiltration of
the salivary and lacrimal gland (LG) leading to dry eye
and dry mouth. Glandular infiltrates are composed of a
mix of dendritic cells, macrophages, CD4+, CD8+, nat-
ural killer (NK), Foxp3+, B cells, dendritic cells [1]. Des-
pite expanding efforts to define the immunopathology of
SS, the underlying molecular mechanisms responsible
for the impaired secretory function of the inflamed LG
remain incompletely understood, as several molecules
have been known to impair secretion in in vitro models,
including interleukin (IL) IL-1, IL-6, nitric oxide (NO),
anti-muscarinic receptor, anti-Ro immunoglobulin G
(IgG) [2-5]. Mouse models that recapitulate some fea-
tures of SS have been used to study the pathogenesis, in-
cluding the IL-2 receptor alpha chain (CD25) knockout
(KO) [6,7].
IL-2 signals through its heterodimer receptor com-
posed of three individual chains. CD25 binds IL-2 with
high affinity and it is considered its main receptor. Mice
lacking CD25 have phenotype similar to mice lacking
IL-2 itself [8,9]. As IL-2 is responsible for expansion and
differentiation of T regulatory cells (Tregs) and also
activation-induced cell death, autoimmunity arises in
both IL-2−/− and CD25−/− strains [6,8,10]. The CD25KO
mouse develops spontaneous multiorgan inflammatory
disease, inclusive of exocrine glands and gastrointestinal
tract, and a profound hemolytic anemia that leads to
early mortality. The spontaneous dacryoadenitis that de-
velops in these mice is age dependent, with 50% of the
LG infiltrated by 8 weeks (W), evolving to complete at-
rophy and periductal fibrosis at age 16 W [7]. Our previ-
ous studies with this mouse strain have found elevated
IL-1β, IL-17 and interferon-gamma (IFN-γ) transcripts
in the LG [7]. We have shown that IL-17A levels in the
LG peak at 8 to 12 W with a steady decline after, sug-
gesting that IL-17 could be involved in earlier disease
development [7,11]. Similar to findings in the nonobese
diabetic (NOD) strain [12], deletion of IFN-γ in the
CD25KO delays onset and severity of dacryoadenitis, but
does not prevent development of lymphocytic infiltra-
tion [13].
IL-17-producing T lymphocytes have been recently
shown to comprise a T helper (Th) lineage known as
Th17 cells, which are distinct from Th1 and Th2 cells.
Th1 cells contribute to host defense of viral, fungal, and
intracellular bacterial infections, and are characterized
by the production of IFN-γ. Th17 cells have been shown
to be involved in the pathogenesis of many autoimmune
and inflammatory diseases, inclusive of SS.
IL-13 regulate IFN-γ both in vitro and in vivo [14]. In
murine models of allergic asthma, mice repeatedly ex-
posed to allergens or IL-13 develop goblet cell hyperplasiaof the airway epithelium [15-17]. IL-13 has also antiapop-
totic effects on airway and colonic epithelia, two tissues
that are rich in goblet cells [18,19]. IL-13 is expressed by
Th2 cells and plays a role in B cell activation.
The specific role of IL-17, IL-13 and IFN-γ in the in-
flammation that develops in the CD25KO has not been
evaluated. To accomplish this, we used several double
knockouts (DKO), including a CD25/IL-17 DKO, a CD25/
IFN-γ DKO as well as a CD25/IL-17/IFN-γ triple KO
(TKO) mouse. Herein we describe that deletion of IL-17
in the CD25KO model accelerates LG lymphocytic infil-
tration and acini apoptosis, due to a high IFN-γ receptor,
high tumor necrosis factor (TNF)-related apoptosis-
inducing ligand (TRAIL), Fas-ligand (Fas-L) and high
caspase-3 and -9 and low local IL-13/IFN-γ ratio, while
the deletion of IFN-γ decreases caspase activity levels and
number of terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL)-positive (+) cells. Deletion of
IL-17A and IFN-γ in the CD25KO (creating a CD25/IL-
17/IFN-γ TKO) ameliorates dacryoadenitis and improves
glandular function, demonstrating that IFN-γ is key to the
autoimmunity in this model.
Methods
Animals
This research protocol was approved by the Baylor Col-
lege of Medicine Center for Comparative Medicine, and
it conformed to the standards in the ARVO Statement
for Use of Animals in Ophthalmic and Vision Research.
CD25+/− (B6.129S4-IL-2ratm1Dw/J), IFN-γKO and C57BL/6 J
mice breeding pairs were purchased from Jackson
Laboratories (Bar Harbor, ME, USA) for establishing of
breeder colonies. IL-17KO mice were kindly provided by
Dr. Yoichiro Iwakura [20].
To create a CD25/IL-17 double KO (CD25−/−IL-17−/−;
CD25/IL-17 DKO), IL-17KO mice were mated with
CD25+/− mice. F1 was genotyped and CD25+/−IL-17+/−
mice were mated. F2 offspring were genotyped. CD25−/−IL-
17−/− were obtained after interbreeding of CD25+/−IL-17−/−
mice. The genotype of KO strains was confirmed using a
previously reported protocol. Mice were used at 4, 8, 12,
16 W. A minimum of 24 animals per age (4, 8, 12, 16
W) per strain (CD25KO, IL-17KO and CD25/IL-17
DKO) were used: five (histology), six (flow cytometry),
eight (gene expression), five (caspase activity). Tear collec-
tion was performed when mice were alive (n = 12). In some
strains/age, up to 20 animals were used for flow cytometry
and up to eight animals were used for caspase activity.
To create a CD25/IL-17/IFN-γ triple TKO (CD25−/−
IL-17−/−IFN-γ−/−), CD25+/−IL-17−/− were mated with
CD25+/−IFN-γ−/− mice. F1 was genotyped and CD25+/−IL-
17+/−IFN-γ+/− were mated again. F2 offspring was geno-
typed and CD25+/−IL-17−/−IFN-γ−/− (IL-17/IFN-γ DKO)
were used as breeders to generate CD25/IL-17/IFN-γ
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very few CD25/IL-17/IFN-γ TKO mice were generated.
The genotype of KO strains was confirmed using a previ-
ously reported protocol. CD25/IL-17/IFN-γ TKO and IL-
17/IFN-γ DKO mice were used at 8, 12, and 16 W: five
(histology), twelve (flow cytometry). An additional six
(4 W) and twelve C57BL/6 mice (six for 4 and 8 W)
were used for histology, tear epidermal growth factor
(EGF) assay and serum collection.
To create a CD25/IFN-γ DKO (CD25−/−IFN-γ−/−),
IFN-γKO mice were mated with CD25+/− mice. F1 was
genotyped and CD25+/−IFN-γ+/− mice were mated. F2
offspring were genotyped. CD25−/−IFN-γ−/− were ob-
tained after interbreeding of CD25+/−IFN-γ−/− mice as
previously described [13]. CD25/IFN-γ DKO were used
at 4 and 8 W: four animals for histology and four ani-
mals for gene expression.
Histology and measurement of total infiltration
Extraorbital LG were excised, fixed in 10% formalin, paraf-
fin embedded, and 8-μm sections were cut as previously
described [13]. Sections were stained with hematoxylin
and eosin (H&E) for evaluating morphology. The area of
lymphocytic infiltration was circumscribed in digital im-
ages of H&E-stained sections as previously described [7].
The percentage infiltration was calculated as area of infil-
tration × 100/total area.
Immunohistochemistry (IHC) and laser confocal
microscopy
Extraorbital LG from each strain/age (n = 5) were ex-
cised, embedded in optimal cutting temperature com-
pound (VWR, Suwanee, GA, USA), and flash frozen in
liquid nitrogen and stored at -80c.
IHC in LG cryosections was performed by using CD4
(BD Pharmingen, San Jose, CA, USA; clone H129.9, 10
μg/ml), CD8a (BD Pharmingen; clone 53e6.7, 3.125 μg/
ml), or CD19 (Abcam, Cambridge, MA, USA; clone
6D5, 2 μg/ml) antibodies. Staining was performed with
appropriate biotinylated secondary antibodies (all from
BD Pharmingen) and a Vectastain Elite ABC kit with
Nova Red reagents (Vector Laboratories, Burlingame,
CA, USA). Secondary antibody alone and appropriate
anti-mouse isotype (BD Biosciences, San Diego, CA,
USA) were used as controls. Six sections from each
animal/group/time point were examined and photo-
graphed with a microscope equipped with a digital
camera (Eclipse E400 with a DS-Fi1; Nikon, Melville,
NY, USA).
Immunofluorescent staining in LG cryosections was
performed by using primary antibodies against Fas-L
or IFN-γ receptor (1:100 for both, sc-834 and sc-703,
respectively; Santa Cruz Biotechnology, Dallas, TX,
USA). The tissue sections (two slides per animal) forimmunofluorescent staining were fixed in acetone
at −20°C for 10 minutes, blocked in 20% normal goat
serum in phosphate-buffered saline (PBS) for 60 mi-
nutes and primary antibodies were applied and incu-
bated for 1 hour at room temperature (RT). Secondary
antibody, Alexa-Fluor 488-conjugated goat anti-rabbit
IgG (1:100 dilution) were applied, sections was incu-
bated in a dark chamber for 1 hour, followed by coun-
terstaining with propidium iodide (PI; 2 μg/mL in PBS)
for 5 minutes. Secondary antibody alone was also per-
formed as negative controls.
Digital confocal images (512 × 512 pixels) were
captured with a laser scanning confocal microscope
(LSM 510, with krypton-argon and He-Ne laser; Carl
Zeiss Meditec, Inc., Thornwood, NY, USA) with 488-
nm excitation and 543-nm emission filters (LP505
and LP560, respectively; Carl Zeiss Meditec, Inc.)
and were acquired with a 40/1.3× oil-immersion ob-
jective. Images from all samples were captured with
identical photomultiplier tube gain settings and were
processed with the microscope system (LSM-PC soft-
ware; Carl Zeiss Meditec, Inc.).
Flow cytometry analysis of infiltrating cells
Single-cell suspensions of LG from all strains were pre-
pared and stained for CD4, CD8 and B220 surface
markers as previously reported [13]. The initial leukocyte
gate in flow cytometry analysis was confirmed to have
greater than 98% of CD45+ cells.
RNA isolation and quantitative PCR
Extraorbital LGs from IL-17KO, CD25KO, CD25/IL-17
DKO, and C57BL/6 were excised and total RNA was ex-
tracted and processed as previously described [13]. Eight
samples per strain/age were used, and one sample con-
sisted of pooled glands from the same animal. First-
strand cDNA was synthesized.
Quantitative real-time PCR was performed with specific
minor groove binder (MGB) probes as previously published
[21]. Murine MGB probes were IFN-γ (Mm00801778),
IL-13 (Mm00434165), IL-4 (Mm00445259), IL-5 (Mm
99999063), hypoxanthine phosphoribosyltransferase
(HPRT1) (Mm00446968), caspase-3 (Mm00438045),
caspase-8 (Mm00802247), caspase-9 (Mm01348848),
major histocompatibility complex class II (MHC-II)
(Mm00482914) TNF-α (Mm99999068), IL-1β (Mm
00434228), IL-17 (Mm00439618), IFN-γ receptor (Mm
00599890), TRAIL (Mm01283606) and Fas-L (Mm
00438864). The HPRT-1 gene was used as an endogenous
reference for each reaction. The results of real time PCR
were analyzed by the comparative CT method and the re-
sults were normalized by the CT value of HPRT-1. The
mean CT of relative mRNA level in the 4-W IL-17KO
group was used as the calibrator.
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assay (ELISA)
ELISA was performed to measure EGF concentrations in
tear fluid washings using a commercial ELISA kit (R&D
Systems, Minneapolis, MN, USA) as previously described
[13]. Tear fluid washings were collected from 12 animals/
strain/age [13]. One sample consisted of tear washings
from both eyes of one mouse pooled (2 μL) in PBS + 0.1%
bovine serum albumin (BSA) (8 μL) and stored at −80°C
until the assay was performed. Results are presented as
mean ± standard deviation (SD) (pg/ml).
Caspase-3, −8, and −9 activation fluorometric assays
The activation of caspase-3, -8, and -9 was measured in
LG lysates according to the manufacturer’s protocol
(K105-200, K112-200, and K118-200, respectively; BioVi-
sion, Inc., Mountain View, CA, USA). Protein concentra-
tion was measured using a micro BSA protein assay kit
(Thermo Fisher Scientific, Waltham, MA, USA). Five to
eight samples per age/strain were used. Caspase-3, -8, and
-9 activities were measured (50 μg/sample) by following
the cleavage of the fluorescent substrate analogs in a fluor-
escent plate reader (Tecan Infinite M200, Magellan V6.55
software; Tecan, Männedorf, Switzerland) with 400-nm
excitation filter and 505-nm emission filter. The results
were exported and averaged.
TUNEL assay
The TUNEL assay was performed with a kit (ApopTag;
Intergen Co., Purchase, NY, USA), in cryosections of LG
(n = 3/strain/age), as previously described [22]. TUNEL+
cells were counted in digital images at 20X within each
group and results averaged.
IL-4, IL-5, IL-13, IL-17 and IFN-γ LUMINEX assay in serum
Concentrations of IL-4, IL-5, IL-13, IL-17 and IFN-γ in
serum were measured using a multiplex Mouse Cyto-
kine Magnetic Bead Panel (Millipex Map Kit; EMD
Millipore Corp, Billerica, MA, USA). Serum was col-
lected from mice (n = 4 to 8/strain) through cardiac
puncture immediately after euthanasia and frozen at −80°C
until ready to use. A 25 μl/sample was used according
to the manufacturer’s protocol. Labeled cytokines were
read by a Luminex 100 with xPONENT 3.1 (Luminex,
Austin, TX, USA). At least 50 events per bead were
read and the data were analyzed using Millipex Analyst
software (EMD Millipore).
Statistical analysis
Two-way analysis of variance (ANOVA) or Kruskall-
Wallis test with Tukey’s post hoc testing was used for
statistical comparisons with alpha of 0.05. These tests
were performed using GraphPad Prism 6.0 software
(GraphPad Software Inc., San Diego, CA, USA).Results
Deletion of IL-17A in the CD25KO worsen dacryoadenitis
Our previous studies showed that CD25KO mice have in-
creased expression of both IL-17A and IFN-γ transcripts
in LG tissue [7] and that deletion of IFN-γ delayed the on-
set and severity of dacryoadenitis in this strain [13]. To
dissect the specific contribution of IL-17A in this model,
we compared CD25KO and CD25/IL-17 DKO mice with
age-matched IL-17KO mice. Neither the CD25KO [13],
nor the IL-17KO strain have a gender bias (data not
shown). No gender difference in severity of LG infiltration
in the CD25/IL-17 DKO or CD25/IL-17/IFN-γ TKO
strain was observed; therefore, the data represent an aver-
age of both genders (1:1) for each parameter/age. In-
creased mortality was seen in CD25/IL-17 DKO strain
compared to CD25KO strain, as early as 5 W, with few
mice reaching 16 W of age. Sparse cell infiltration was
observed around the ducts in IL-17KO LG, while both
CD25KO and CD25/IL-17 DKO showed increased lym-
phocytic infiltration (approximately 40% and approxi-
mately 80% respectively, Figure 1A, B) at 4 W. After 8 W,
both CD25KO and CD25/IL-17 DKO had similar total ac-
inar loss, ductal proliferation, which progressed to atrophy
by 16 W. Normal acini were seen in CD25/IL-17 DKO LG
only at 4 W (Figure 1A, B).
As a measurement of LG secretory function, EGF con-
centration in tears was measured as previously described
[13]. A progressive increase in EGF concentration in tears
of IL-17KO mice was seen as they aged, suggesting normal
maturation and function of LG epithelia (Figure 1C). Both
CD25KO and CD25/IL-17 DKO had significantly lower
EGF concentration compared to IL-17KO mice at all ages.
CD25/IL-17 DKO showed a significantly greater percent-
age of CD4+ cells than the CD25KO strain at 4 and 12 W
(Figure 2A). Flow cytometry showed a predominance of
CD8+ T cells over CD4+ T cells in CD25KO and CD25/IL-
17 DKO LGs at all ages compared to IL-17KO mice
(Figure 2C). CD4 and CD8+ T cells were mainly seen
around ducts (Figure 2B, D). CD25KO had the greatest per-
centage of B220+ cells compared to IL-17KO (at all ages)
and higher percentage than CD25/IL-17 DKO (Figure 2E)
at 8 and 12 W. Minimal CD19+ B cell infiltration was ob-
served in IL-17KO at all ages (Figure 2F). Sparse infiltrating
CD19+ cells were seen in CD25/IL-17 DKO and CD25KO
at 4 W whereas they were easily identified as these mice
aged (Figure 2F). Two types of CD19+ B cell infiltration
were observed: the first resembled IL-17KO LGs, where B
cells were dispersed throughout the gland and did not accu-
mulate in foci, while the second was suggestive of germinal
center formation within the LG (Figure 2F, aged 8 to 16 W).
Taken together, these results show that deletion of IL-
17A in the CD25KO model of SS accelerated LG de-
struction and promoted progressive increased lymphocytic
infiltration.
Figure 1 Accelerated and more severe dacryoadenitis in CD25/IL-17 DKO LG. (A) Representative images of H&E-stained LG from mice aged
4 to 16 weeks (W). The square is a higher magnification of the area underneath. Scale bar = 100 μm. (B) Percent area of lymphocytic infiltration
measured in digital images of H&E-stained LG sections from IL-17KO, CD25/IL-17 DKO and CD25KO mice at 4, 8, 12, and 16 W. (C) EGF concentration
measured in tear washings from different strains. *P <0.05;**P <0.01, ***P <0.001; ****P <0.0001 within strain comparison vs. 4 W. ^P <0.05; ^^P <0.01,
^^^P <0.001; ^^^^P <0.0001 interstrain comparison. CD25/IFN-γ DKO, CD25−/−IFN-γ−/−; CD25KO, CD25 knockout; DKO, double knockout; EGF, epidermal
growth factor; H&E, hematoxylin and eosin; IL, interleukin; IL-17KO, IL-17 knockout; KO, knockout; LG, lacrimal gland.
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IL-17 DKO LG
To investigate the phenotype of infiltrating cells, we evalu-
ated the expression of MHC II, inflammatory cytokines
(IL-1β, TNF-α), IL-13, IFN-γ, IFN-γ receptor (IFN-γR)
and IL-13 using the 4 W IL-17KO LG as calibrator con-
trol, since this control strain had minimal T cell infiltration
(Figure 3). Real-time PCR analysis showed that IL-1β,
TNF-α, IFN-γ and MHC II were all significantly elevated
in CD25/IL-17 DKO and CD25KO compared to IL-17KO
LG at all ages, although aging from 4 to 16 W significantlyincreased levels of IL-1β, TNF-α and MHC II transcripts
in IL-17KO mice.
Expression of IL-1β mRNA was higher in CD25KO at
4 W, and expression of IFN-γ mRNA was higher at both
4 W and 8 W. By 8 W and 12 W, expression of both
transcripts was higher in CD25/IL-17 DKO.
Although the level of TNF-α transcripts was similar in
CD25KO and CD25/IL-17 DKO at 4 W, it increased
steadily in CD25KO from 4 to 12 W, while in the CD25/
IL-17 DKO it did not change until 16 W, when it was
significantly higher than CD25KO.
Figure 2 Lacrimal gland infiltrates. (A, C, E) Percentage of CD4+ T (A); CD8+ (C) and B220+ cells (E) gated by flow cytometry of LG cells from IL-17KO,
CD25KO, CD25/IL-17 DKO mice aged 4 to 16 weeks of age (W). Data are presented as mean ± SEM of six to twelve individual samples/strain/age.
(B, D, F) Representative images of immunohistochemistry of LG sections stained for CD4 (B), CD8 (D) and CD19 (F) positive cells (stained in red) in
sections obtained from all three strains. Scale bar = 100 μm. *P <0.05; **P <0.01, ***P <0.001; ****P <0.0001 within strain comparison vs. 4 W. ^P <0.05;
^^P <0.01, ^^^P <0.001; ^^^^P <0.0001 interstrain comparison. CD25/IFN-γ DKO, CD25−/−IFN-γ−/−; CD25KO, CD25 knockout; DKO, double knockout;
IL, interleukin; IL-17KO, IL-17 knockout; LG, lacrimal gland; SEM, standard error of the mean.
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a bimodal distribution peaking at 8 W (approximately
27-fold) and 16 W (31-fold), while in the CD25/IL-17
DKO it increased gradually, reaching the same level as
the CD25KO at 12 W.
IL-13 has been described to be antiapoptotic in co-
lonic and airway epithelial cells as well as conjunctival
fibroblasts [18,19,23]. Expression of IL-13 mRNA in the
CD25KO increased over a biphasic time course.
Expression in CD25/IL-17 DKO was markedly sup-
pressed compared to CD25KO at 4 W, 8 W, and 16 W
(Figure 3). IL-4 and IL-5 transcripts were barely de-
tected in some samples and were undetected in many
samples.Our results indicate that CD25/1L-17 DKO mice have
greater expression of IL-1β, while lower levels of IL-13
than CD25KO, but both strains had increased TNF-α
and MHC II compared to IL-17KO. CD25KO LG have
increased IL-17A, IFN-γ and IL-13, while CD25/IL-17
DKO mice have only elevated IFN-γ. IL-13 may have a
protective role counteracting IFN-γ, as higher levels of
IL-13 transcripts were seen in CD25KO mice, which had
less severe disease than the CD25/IL-17 DKO.
Systemic Th2 cytokines are suppressed in the CD25/IL-17
DKO compared to the CD25KO
IL-17A serum levels were 10-fold higher in CD25KO
mice than C57BL/6 mice at 8 W (78.82 ± 48 vs. 7.57 ±
Figure 3 Comparison of inflammatory markers and T cell-related cytokines in LG of knockouts. Relative fold of expression of IL-1β, TNF-α,
MHC II, IFN-γ, IL-13 and IFN-γ receptor. Data are presented as mean ± SEM of eight individual samples/strain/age. *P <0.05; **P <0.01, ***P <0.001; ****P
<0.0001 within strain comparison vs. 4 weeks. ^P <0.05; ^^P <0.01, ^^^P <0.001; ^^^^P <0.0001 interstrain comparison. IFN-γ, interferon-gamma; IL, interleu-
kin; LG, lacrimal gland; MHC-II, major histocompatibility complex class II; SEM, standard error of the mean TNF-α, tumor necrosis factor alpha. R = receptor.
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temic increase in IFN-γ was measured in serum of
CD25/IL-17 DKO mice as they aged from 4 to 12 W
(Figure 4A). IL-13 levels in serum mirrored gene ex-
pression in the LG as they were significantly elevated inFigure 4 Comparison of T helper cell-related cytokines in serum of kno
IL-17KO, CD25/IL-17 DKO, CD25KO mice. Data are presented as mean ± SEM o
IL-13/IFN-γ ratio of serum from IL-17KO, CD25/IL-17 DKO, CD25KO mice. *P <0
weeks. ^P <0.05; ^^P <0.01, ^^^P <0.001; ^^^^P <0.0001 interstrain comparison
double knockout; IFN-γ, interferon-gamma; IL, interleukin; IL-17KO, IL-17 knockCD25KO at all ages compared to CD25/IL-17 DKO
(Figure 4A). IL-4 and IL-5 levels in serum of CD25KO
were significantly increased in CD25KO at 4 and 8 W
compared to CD25/IL-17 DKO and low levels were mea-
sured in IL-17KO at all ages (Figure 4A). The IL-13/IFN-γckouts. (A) Concentration of IFN-γ, IL-13, IL-4 and IL-5 in serum from
f eight individual strains/ages. (B) Bar graph showing mean ± SEM of
.05; **P <0.01, ***P <0.001; ****P <0.0001 within strain comparison vs. 4
. CD25/IFN-γ DKO, CD25−/−IFN-γ−/−; CD25KO, CD25 knockout; DKO,
out; LG, lacrimal gland; SEM, standard error of the mean; W, weeks.
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showed that CD25KO have a higher IL-13 systemic re-
sponse than CD25/IL-17 DKO (Figure 4B). The IL-4/IFN-
γ and IL-5/IFN-γ ratio in CD25/IL-17 DKO was also
lower compared to CD25KO mice (data not shown).
Taken together, these results showed that CD25KO
mice have high levels of systemic Th1, Th17 and Th2
signature cytokines but an unchecked systemic elevated
Th1 response (with low levels of Th2) is observed with
aging in the CD25/IL-17 DKO mice.
Role of IL-17 and IFN-γ in the LG apoptosis in CD25KO
mice
We have previously demonstrated a proapoptotic role of
IFN-γ in our inducible dry eye model, as antibody
neutralization of IFN-γ prevented desiccation-induced
goblet cell loss [24]. Because we found high IFN-γ and low
IL-13 transcripts in CD25/IL-17 DKO mice, we hypo-
thesize that these mice might be more susceptible to the
apoptotic effects of IFN-γ due to its lower IL-13 levels,
since IL-13 has been shown to have antiapoptotic effects
and to downregulate IFN-γR expression [18,19]. To ad-
dress this, we investigated IFN-γR expression by real-time
PCR and immunostaining. Both CD25KO and CD25/IL-
17 DKO had higher expression of IFN-γR at 4 W
compared to IL-17KO; but greater mRNA levels were ob-
served in CD25/IL-17 DKO LG compared to CD25KO at
8 and 12 W (Figure 5A). Immunostaining evaluated pro-
tein expression at 4 and 8 W because these ages had the
greatest differences. Minimal immunoreactivity for IFN-
γR was present in IL-17KO and C57BL/6 (Figure 5A),
while increased immunostaining was seen in the LG ducts
in both CD25KO and CD25/IL-17 DKO at 4 W, which in-
creased as these mice aged to 8 W.
Since expression of Fas-L on infiltrating lymphocytes
has been shown to cause apoptosis to surrounding cells
[25-27], we investigated the expression of Fas-L and
TRAIL. Fas-L was significantly increased in both CD25KO
and CD25/IL-17DKO compared to IL-17KO, and IL-17
DKO had significantly higher levels of Fas-L at 4, 8 and 16
W compared to CD25KO.
There was an age-progressive increase in TRAIL mRNA
levels in CD25/IL-17 DKO LG from 4 to 8 W and it was
significantly higher than CD25KO LG at 12 W (Figure 5B).
Because Fas-L and IFN-γ-mediated apoptosis ultimately
involves activation of caspases [24,28], we investigated
apoptotic pathway mediators in LG lysates. Caspase-3 is
the final common apoptosis pathway, while caspase-9 is
involved in the intrinsic pathway and caspase-8 is involved
in the extrinsic one. Caspase-3, -8, -9 mRNA levels were
elevated in CD25/IL-17 DKO and CD25KO compared to
IL-17KO at 8, 12 and 16 W (Figure 5C). A progressive in-
crease in caspase-3 and -8 transcripts expression was seen
in CD25/IL-17 DKO LG as these mice aged. Significantlyhigher levels of caspase-3, -8 and -9 were seen in CD25KO
at 4 W compared to the CD25/IL-17 DKO. Caspase-3
transcripts were significantly upregulated in CD25/IL-17
DKO, while caspase-8 and -9 were equally elevated in
both CD25KO and CD25/IL-17 DKO at 8 W. Results
from gene expression were confirmed by caspase activity
assays. IL-17KO had the lowest caspase activity levels
among all three strains, corroborating the PCR results.
Compared to CD25KO mice, CD25/IL-17 DKO LG had
significantly higher caspase-3, and -9 activity levels at 4 W
and significantly higher caspase-3, -8 and -9 activity levels
at 8 W (Figure 5D). An increase with aging from 4 to 8 W
within the CD25/IL-17 DKO LG was observed for
caspase-3 and -8.
TUNEL detects fragmented DNA, another sign of apop-
tosis. Increased TUNEL+ cells were seen in LG sections of
both CD25/IL-17 DKO and CD25KO at 4 W compared to
IL-17KO LG control (459 ± 16.72 and 281 ± 14.29 vs.
81.67 ± 7.56 TUNEL+ cells/20X field, P <0.0001 for both,
respectively, Figure 5E and F). TUNEL+ cells were seen in
the glandular epithelial cells, but not in the infiltrating
cells (Figure 5E). At 8 W, a further increase in TUNEL+
cells was seen in the CD25/IL-17 DKO mice compared to
its baseline (1,100.67 ± 101.85 vs. 459 ± 16.72 TUNEL+
cells/20X field, P <0.0001).
These results suggest that increased IFN-γR expres-
sion in the CD25/IL-17 DKO mice sensitizes them to
IFN-γ-induced apoptosis and these changes may be po-
tentiated in the low antiapoptotic IL-13 environment of
this strain compared to CD25KO.
Deletion of IFN-γ in CD25KO decreases apoptosis
We have shown that antibody neutralization of IFN-γ pre-
vented desiccation-induced increase in caspase-3 mRNA
and immunoreactivity while exogenous administration of
IFN-γ during desiccating stress induced caspase-9 mRNA
and activity [24,29]. To confirm the role of IFN-γ in pro-
moting glandular apoptosis in the CD25KO model, we
evaluated caspase activity in LG protein lysates and per-
formed TUNEL assay in CD25/IFN-γ DKO LG cryo-
sections at 4 W and 8 W. These mice have significantly
delayed and less severe dacryoadenitis compared to
CD25KO mice at 8 W [10]. We observed significantly
lower caspase-3 and -9 activity levels in CD25/IFN-γ
DKO LG compared to CD25KO at 8 W and CD25/IL-17
DKO (Figure 5D). Although the level of caspase-8 activity
was significantly lower than the CD25/IL-17 DKO, it was
not different from CD25KO mice (Figure 5D).
CD25/IFN-γ DKO at 4 and 8 W had very few TUNEL+
cells, and they were significantly lower than CD25KO
parental strain (101 ± 14 and 143 ± 17.44 vs. 281 ± 14.29
and 429 ± 23.24 TUNEL+ cells/20X field, P <0.001 and
P <0.0001, respectively, Figure 5E and F). These results
confirm the pathogenic role of IFN-γ in inducing glandular
Figure 5 Comparison of apoptosis among different double knockouts. (A) Representative merged images of laser scanning immunofluorescent confocal
micrographs of LG immunostained for IFN-γ receptor (IFN-γR, green) with propidium idodide counterstaining (red) in IL-17KO, CD25KO, CD25/IL-17 DKO, CD25/
IL-17/IFN-γ TKO, IL-17/IFN-γ DKO and C57BL/6. Scale bar = 50 μm. (B-C) Relative fold of expression of Fas-L and TRAIL (B) and caspase-3, -8 and -9 (C) in LG
lysates of IL-17KO, CD25/IL-17 DKO and CD25KO mice aged 4 to 8 weeks (W). Data are presented as mean± SEM of eight individual samples/strains/ages. (D)
Caspase-3, -8 and -9 activity assay results from LG lysates of IL-17KO, CD25/IL-17 DKO, CD25KO and CD25/IFN-γ DKO mice aged 4 to 8 W. Data are presented as
mean± SEM of five to eight individual samples/strains/ages. (E) Representative merged images of laser scanning fluorescent confocal micrographs of TUNEL-
stained LG (green) with propidium iodide counterstaining (red) in IL-17KO, CD25KO, CD25/IL-17 DKO, CD25/IL-17/IFN-γ TKO, IL-17/IFN-γ DKO, C57BL/6 and
CD25/IFN-γ DKO mice used to generate the bar graphs in (F) Scale bar = 50 μm. F. TUNEL+ cells (mean± standard deviation (SD)) among the different groups.
*P <0.05; **P <0.01, ***P <0.001; ****P <0.0001 within strain comparison vs. 4 W. ^P <0.05; ^^P <0.01, ^^^P <0.001; ^^^^P <0.0001 interstrain comparison. CD25/IFN-
γ DKO, CD25−/−IFN-γ−/−; CD25/IL-17/IFN-γ TKO, CD25−/−IL-17−/−IFN-γ−/−; CD25KO, CD25 knockout; DKO, double knockout; Fas-L, Fas-ligand; IFN-γ, interferon-
gamma; IL-17/IFN-γ DKO, CD25+/−IL-17−/−IFN-γ−/−; IL, interleukin; IL-17KO, IL-17 knockout; LG, lacrimal gland; SEM, standard error of the mean; TKO, triple knockout;
TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing ligand; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; W, weeks.
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as deletion of IFN-γ in the CD25KO model significantly
decreases caspase activity levels and TUNEL+ cells.
Deletion of IFN-γ in CD25/IL-17 DKO ameliorates SS-like
disease
Next we investigated if deletion of IFN-γ in the CD25/IL-
17 DKO mouse would diminish LG disease by generating
a CD25/IL-17/IFN-γ TKO mouse (CD25−/−IL-17−/−IFN-
γ−/−) and compared to IL-17/IFN-γ DKO littermates
(CD25+/−IL-17−/−IFN-γ−/−). Similar to parental strains, no
gender predilection was seen (not shown).
IL-17/IFN-γ DKO had normal-appearing LG with min-
imal lymphocytic infiltration at all ages (4 to 16 W), while
in CD25/IL-17/IFN-γ TKO mice areas of immune infil-
trates were seen at 8 W (20% of total LG) and progres-
sively increased up to 16 W, compromising about 60% of
the LG area (Figure 6A and B). Tear EGF concentration in
CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ DKO mice was
in the normal range at 8 W; however, a significant de-
cline in tear EGF concentration was seen in CD25/IL-
17/IFN-γ TKO as they aged to 16 W (Figure 6C).
Histologically, a mix of CD4+, CD8+ and CD19+ cells was
seen in the LG, with a greater number of CD4+ (Figure 6D)
and CD8+ (not shown) in the CD25/IL-17/IFN-γ TKO
compared to IL-17/IFN-γ DKO mice. Flow cytometric ana-
lyses indicated that the immune cell aggregates consisted
of CD4+, CD8+ T cells, and B lymphocytes (Figure 6E).
There was an increased percentage of CD4+ and CD8+ in
CD25/IL-17/IFN-γ TKO compared to IL-17/IFN-γ DKO
mice (8 W to 16 W), with a predominance of CD8+ cells.
There was a significant increase in CD4+ cells at 12 W
compared to 8 W in CD25/IL-17/IFN-γ TKO mice, paral-
leling increased lymphocytic infiltration seen in histologic
sections. IL-17/IFN-γ DKO had the highest percentage of
B cells (Figure 6E).
Gene expression could not be evaluated in the LG of
CD25/IL-17/IFN-γ TKO mice due to difficultly breeding
of this strain. To investigate whether the CD25/IL-17/
IFN-γ TKO mice had a compensatory elevation of IL-13
as seen in CD25KO mice, we measured serum IL-13
concentration. Our results demonstrated no difference
in IL-13 levels with age or between CD25/IL-17/IFN-γ
TKO and IL-17/IFN-γ DKO groups (Figure 6F).
Because we observed delayed and less severe dacryoade-
nitis when IFN-γ was deleted in the CD25KO mice, we
sought to investigate whether IFN-γR expression and
TUNEL+ cells were also decreased in the CD25/IL-17/
IFN-γ TKO mice. IFN-γR immunostaining in LG at 4 and
8 W showed very minimal immunoreactivity in glandular
tissue in IL-17/IFNγ DKO (Figure 5A) while a mild ex-
pression was seen in CD25/IL-17/IFN-γ TKO mice.
IL-17/IFN-γ DKO had similar levels of TUNEL+ cells to
nonimmune C57BL/6 mice (53.25 ± 16.04 vs. 32 ± 6.75TUNEL+ cells/20X field, respectively, P >0.05, Figure 5E
and F), while CD25/IL-17/IFN-γ TKO mice had mild dis-
persion of TUNEL+ cells in the LG at 8 W, although it
was still much lower than CD25KO and CD25/IL-17
DKO mice (215.67 ± 23.24 vs. 429 ± 64.59 and 1,100 ±
101.85 TUNEL+ cells/20X field, P <0.001 and P <0.0001,
respectively, Figure 5E and F).
These results confirm that increased IFN-γR expression
in CD25/IL-17 DKO is associated with the increased
apoptosis and increased severity of dacryoadenitis in the
CD25KO mouse model of SS. Even though CD25/IL-17/
IFN-γ TKO mice had increased disease compared to IL-
17/IFN-γ DKO, it was much less severe than the CD25KO
and CD25/IL-17 DKO parental strains, demonstrating that
IFN-γ has a greater pathogenic role than IL-17A.
Discussion
Our results showed that deletion of IL-17A in the
CD25KO model accelerated onset and severity of dacryoa-
denitis. This was accompanied by increased CD4+ and
CD8+ T cell infiltration and increased expression of in-
flammatory cytokines, IFN-γR, Fas-L and TRAIL, lower
levels of local and systemic IL-13 and increased LG apop-
tosis than CD25KO mice. CD25/IFN-γ DKO mice had
lower activity levels of caspase-3, and -9 and significant
lower number of TUNEL+ cells. Deletion of IFN-γ from
CD25/IL-17 DKO (generating a CD25/IL-17/IFN-γ TKO)
had an inverse effect to CD25/IL-17 DKO, preserving
glandular tissue and delaying dacryoadenitis severity.
Tear dysfunction (reduced tear production or in-
creased inflammatory tear content) is responsible for
some severe forms of dry eye and may be caused in part
by cytokines such as IL-1 that are released by infiltrating
cells or stressed glandular epithelial cells. In the present
study, IL-1β transcripts in CD25/IL-17 DKO mice at all
ages were significantly higher than in CD25KO mice and
paralleled the lymphocytic infiltration in these mice. The
proinflammatory and apoptotic effects of IL-1 in the LG
have been extensively studied [30,31]. A single injection
of IL-1 into the extraorbital LG induced a mild decrease
in LG secretion, while inducing a robust, yet reversible
(7 to 13 days) inflammatory response that led to destruc-
tion of LG acinar epithelial cells [30]. Similar to these
studies, the increased IL-1β in LG of CD25/IL-17 DKO
may be critical in inducing inflammatory response in
these CD25/IL-17 DKO mice.
Interestingly, both IL-1 and TNF-α can upregulate
expression of IFN-γR [32] and IL-1 was significantly
increased in the CD25/IL-17 DKO mice. Increased expres-
sion of IFN-γR in CD25/IL-17 DKO may sensitize to the
effects of IFN-γ that is secreted by T cells and NK cells.
Deletion of IFN-γR in the autoimmune MRL/lpr mice pre-
vented apoptosis of the tubular epithelial cells and devel-
opment and severity of kidney autoimmune disease [33].
Figure 6 Less severe SS-like disease in CD25/IL-17/IFN-γ TKO mice. (A) Percentage of lymphocytic infiltration measured in digital images of
H&E-stained LG sections from CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ DKO mice aged 4 to 16 weeks (W). (B) Representative images of H&E-stained
LG sections from CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ DKO mice aged 4 to 16 weeks (W). The square is a higher magnification of the area
underneath. Scale bar = 100 μm. (C) EGF concentration measured in tear washings from different strains (n = 6 to 20 per age/strain). (D) Representative
images of immunohistochemistry for LG sections stained for CD4+ T cells (red) CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ DKO mice aged 4 to 16 W. Scale
bar = 100 μm. (E) Percentage of CD4+ T, CD8+ T and B220+ cells gated in flow cytometry from LG isolated from CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ
DKO LG isolates from mice aged 8 to 16 W. Data are presented as mean ± SEM of six individual samples/strain/age. (F) Concentration of IL-13 in serum
from CD25/IL-17/IFN-γ TKO and IL-17/IFN-γ DKO mice aged 4 to 16 W. Data are presented as mean ± SEM of five to ten individual samples/strains/age.
*P <0.05; **P <0.01, ***P <0.001; ****P <0.0001 within strain comparison vs. 4 W (B and C) or 8 W (E and F). ^P <0.05; ^^P <0.01, ^^^P <0.001; ^^^^P <0.0001
interstrain comparison. CD25/IL-17/IFN-γ TKO, CD25−/−IL-17−/−IFN-γ−/−; DKO, double knockout; EGF, epidermal growth factor; Fas-L, Fas-ligand; H&E,
hematoxylin and eosin; IFN-γ, interferon-gamma; IL-17/IFN-γ DKO, CD25+/−IL-17−/−IFN-γ−/−; IL, interleukin; LG, lacrimal gland; SEM, standard error of the
mean; SS, Sjögren’s syndrome; TKO, triple knockout.
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sensitivity of colonic epithelial cells to diverse apoptotic
stimuli in concert, via upregulation of caspase-1 [34].
MHC II expression can be induced by IFN-γ. LG epithe-
lial cells trigger or exacerbate lacrimal autoimmune dis-
ease by presentation of autoantigens via MHC II [35]. In
our study, higher MHC II transcripts were found in both
CD25KO and CD25/IL-17 DKO mice suggesting a greater
potential of MHC II+ cells to initiate autoimmunity.The CD25KO model is a unique system where auto-
immunity develops spontaneously in many organs, in-
cluding salivary gland [6], lacrimal gland [7] and liver
[11] and it is age-dependent [36]. IL-17A serum levels
[11] and transcripts in LG [7] of CD25KO mice peaked
early (around 8 to 12 W) suggesting that IL-17A could
be participating in early disease development. The num-
ber of autoimmune diseases that have been shown to
have an IL-17 component has increased after discovery
Bian et al. Arthritis Research & Therapy  (2015) 17:53 Page 12 of 15of IL-17, including SS [37]. Elevated levels of IL-17A
protein were found in minor salivary glands and con-
junctiva of SS patients compared to normal control
subjects [21,38]. Our group and others showed that
neutralization of IL-17A ameliorates corneal barrier dis-
ruption in response to desiccating stress [21,39] and de-
creases expression of matrix metalloproteinase (MMP)-3
and MMP-9 mRNA in the corneal epithelium [21]. Des-
pite the fact that increased IL-17 mRNA and protein has
been found in LG of mouse models of SS [7,37,40], the
exact role of IL-17 in the LG remains unsolved. Most of
the published studies describing a pathogenic role for
IL-17A evaluated the salivary gland without description
of the LG. Adenovirus-mediated transfer of an IL-17A
gene vector to the salivary gland ducts of nonimmune
C57BL/6 mice was sufficient to induce an SS-like dis-
ease, inclusive of lymphocytic infiltration and decreased
salivary flow [41]. Adenovirus-mediated transfer of IL-
17R:FC decreased sialodenitis in the susceptible C57BL/
6.NOD-Aec1Aec2 strain [42]. Furthermore, IL-17KO
mice that adoptively received Th17 cells from mice im-
munized with salivary glands extracts had reduced saliva
secretion, elevated autoantibody production and pro-
nounced inflammation and tissue damage in the sub-
mandibular gland [43]. However, in most of these
inducible models, IL-17 response was solely induced
without the confounding interaction with other T cell
cytokines, such as IFN-γ and IL-13.
The role of IL-17A may also be tissue specific; in dex-
tran sodium sulphate induced-colitis, IL-17 is protective,
since neutralization of IL-17 worsened colitis [44] while
CD25/IL-17 DKO mice had more severe autoimmune bil-
iary disease [45]. Regarding the LG, genetic deletion of IL-
17A in an elevated unchecked IFN-γ environment in the
CD25KO mice did not abolish development of auto-
immunity; rather, it accelerated its onset as evidenced by
increased LG lymphocytic infiltration and reduced func-
tion measured by decreased EGF concentration in tears.
In some experimental models, such as experimental
autoimmune uveitis (EAU) both IL-17 and IFN-γ seem to
be pathologic [46-48]. Our results evaluating the CD25/
IL-17/IFN-γ TKO showed that IFN-γ is more pathogenic
than IL-17A, since deletion of IFN-γ in the CD25/IL-17
DKO reversed the acute and severe changes observed in
this model, also decreasing IFN-γR expression and de-
creasing apoptotic cells. However, because these mice still
have a defective IL-2 signaling, disease was not completely
abolished. IL-2 is a master regulator of the immune sys-
tem and it is involved in generation of Tregs, activation-
induced cell death and suppression of Th17 generation
[6,10,49] and it is critical for Th1 function. Recent studies
showed that reduced Treg cell function may contribute to
the development of multiorgan systemic autoimmune dis-
ease [6]. Spontaneous development of dacryoadenitis andkeratoconjunctivitis is observed in mouse strains with de-
fective Treg functions [50,51]. In NOD mice, the deletion
of Treg cells worsens autoimmune activity [52]. In an at-
tempt to dissect the individual contributions of lack of
Tregs and increased life span of activated T cells, cross-
breeding of CD25KO with B6.lpr mice improved survival
and decreased colonic and LG infiltration, demonstrating
that some tissue effects are independent of Tregs [10]. We
observed increased Fas-L and TRAIL expression in CD25/
IL-17 DKO mice, which have the greatest apoptosis, glan-
dular tissue loss and lymphocytic infiltration compared to
parental strains. This is extremely important as increased
Fas-L expression in T cells damages adjacent cells, as dem-
onstrated in CD25/B6.lpr mice and other systems [25-27].
We observed higher EGF concentration levels in IL-
17/IFN-γ DKO than IL-17KO. It is possible that the LG
acini may be very sensitive to low amounts of IFN-γ and
may account for the differences observed in these two
strains. IFN-γ has been described to be critical for LG
and salivary gland development [53,54]. IFN-γ induces
apoptosis, death and structural changes to human saliv-
ary gland cultures [55,56]. In an in vitro model, mouse
conjunctival explant cultures are exquisitely sensitive to
IFN-γ: minute concentrations of IFN-γ at the early days
of culture are sufficient to change morphology and in-
duce apoptosis [57]. Our findings describing the CD25/
IL-17/IFN-γ TKO demonstrate that IFN-γ appears to
make a greater contribution to LG inflammation and
secretory dysfunction than IL-17, which make actually
have some protective functions. We believe that disrupt-
ing the balance of T helper cytokines can alter disease
manifestations.
The cross-regulation of IL-13 and IFN-γ has been well
established in in vitro and in vivo models of asthma
[14,58,59] and IL-13 has been shown to be protective to
epithelium in vitro [18,19,23]. IL-13 can be produced by
Th2 cells and also NK cells [60,61]. We have also shown
that IL-13 is critical for maintenance of conjunctival gob-
let cell. IL-13KO have lower goblet cell density at baseline
and exogenous administration of IL-13 to wild-type mice
is capable of rescuing goblet cell after desiccation-induced
stress [60]. The conjunctiva, similarly to the airway epithe-
lia, is very susceptible to apoptotic effects of IFN-γ; IFN-
γKO are resistant to desiccation-induced goblet cell loss
while exogenous subconjunctival injection of IFN-γ in
these mice recapitulate the phenotype observed in
wild-type mice [62]. In the parental CD25KO strain,
there is a spontaneous proliferation of Th1, Th17 and
Th2 cells. IL-13 has been shown to be antiapoptotic on
colonic and airway epithelial as well as conjunctival fi-
broblasts [18,19,23]. Our results in this manuscript
suggest that in a low IL-13 environment in the pres-
ence of increased IFN-γ and IFN-γR contribute to in-
creased glandular apoptosis.
Figure 7 Severity of dacryoadenitis among autoimmune and
nonimmune strains at 8 weeks of age. Total infiltration was
measured in paraffin-embedded H&E-stained LG sections as
described in materials and methods. H&E, hematoxylin and eosin;
LG, lacrimal gland.
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and -9 and lower number of TUNEL+ cells in the
CD25KO mice compared to the CD25/IL-17DKO and
even lower levels in CD25/IFN-γ DKO compared to
CD25KO mice, demonstrating that IFN-γ is critical for
the glandular apoptosis. CD25/IFN-γ DKO mice had de-
layed glandular destruction and preserved secretory func-
tion at 8 W [13], in agreement with findings in the NOD
model of SS where deletion of IFN-γ improved sialodeni-
tis, decreased caspase-3 activity and TUNEL+ cells com-
pared to parental NOD strain [12]. We have also shown
that in our inducible dry eye model neutralization of IFN-
γ decreased caspase-3 and caspase-8 and increased con-
junctival goblet density [24,29]. Desiccating stress by itself
did not increase caspase-9; however, exogenous adminis-
tration of IFN-γ during desiccating stress upregulated
caspase-9 RNA [24,29]. These results indicate that IFN-γ
actively participates in the dacryoadenitis in the CD25KO
model through inducing the intrinsic (caspase-9) and
common apoptotic (caspase-3) pathways.
We wish to emphasize that this is the first report of
using a combination several DKOs and one TKO in an
attempt to dissect individual contributions of IL-17A
and IFN-γ in dacryoadenitis in a murine model. There
are certainly some limitations to our study. The disease
and LG disarrangement is rather severe and accelerated
in the CD25KO mouse, while in humans it may be more
insidious and chronic in nature. Although we could not
directly prove the involvement of IL-13 in protecting
lacrimal epithelium we speculate that an intact Th2 and
B cell response in CD25KO mice delays development of
pathological infiltrates and destruction of parenchymaltissue based on our findings. Additional studies will cer-
tainly help dissect the exact contribution of IL-13 in the
lacrimal gland immunopathology that develops in the
CD25KO mice.Conclusions
Taking in consideration what we learned through select-
ive removing genes encoding pathogenic factors in the
CD25KO strain, we assembled the graph in Figure 7 that
grades severity based on the percentage of total lympho-
cytic infiltration of the LG at 8 W. A gradient of LG in-
filtration can be observed, where the CD25/IL-17 DKO
has the worst disease, while the CD25/IFN-γ DKO [13]
is on the other end of the spectrum with much less se-
vere disease. Severity of LG infiltration in the IL-17/IFN-
γ DKO and IFN-γKO is similar to that seen in C57BL/6
mice. These results suggest that therapies targeting both
cytokines may be more beneficial in the treatment of SS
than targeting a single cytokine.Abbreviations
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